Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance

• Asıl Yazarlar: Xue Han (Yazar), Ruijuan Su (Yazar), Xiuqing Huang (Yazar), Yingli Wang (Yazar), Xiao Kuang (Yazar), Shuang Zhou (Yazar), Hongzhuo Liu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2019-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Mitochondria are currently known as novel targets for treating cancer, especially for tumors displaying multidrug resistance (MDR). This present study aimed to develop a mitochondria-targeted delivery system by using triphenylphosphonium cation (TPP+)-conjugated Brij 98 as the functional stabilizer...